Infectious Diseases

Yesterday, the World Health Organization gave the virus a new name: COVID-19.

The total numbers far exceed the toll of the 2003 SARS outbreak

Meanwhile, WHO holds meeting on fast-tracking vaccines, treatments for novel virus

In the last 24 hours, agency has recorded the largest increase in cases since the start of the epidemic.

The FDA has accepted for review a supplemental New Drug Application (sNDA) for Recarbrio­­­™ (imipenem, cilastatin, and relebactam; Merck), to treat adult patients with hospital-acquired and ventilator-associated bacterial pneumonia.

Trial to be conducted in the central Chinese city of Wuhan, the epicenter of the outbreak.

NIH-sponsored trial was being conducted in South Africa.

The FDA has approved Audenz (influenza A [H5N1] monovalent vaccine; Seqirus) for active immunization for the prevention of disease in patients 6 months of age and older at increased risk of exposure to the influenza A H5N1 virus subtype contained in the vaccine.

Most early cases, but fewer subsequent cases, were linked to Huanan Seafood Wholesale Market.

The first instance of person-to-person spread of the 2019 novel coronavirus (2019-nCov) has been confirmed in the US, according to the Centers for Disease Control and Prevention (CDC).